Screener
Adaptive Biotechnologies ADPT Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $2.14B.
The source filing: Adaptive Biotechnologies’s 10-Q, filed May 5, 2026. Open the filing →
- Filed
- May 5, 2026, 4:30 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-206546
FAQ
- What is Adaptive Biotechnologies's market capitalization?
- Adaptive Biotechnologies (ADPT) reported market capitalization of $2.14B in Q1 2026.
- How has Adaptive Biotechnologies's market capitalization changed year-over-year?
- Adaptive Biotechnologies's market capitalization increased by 93.6% year-over-year, from $1.1B to $2.14B.
- What is the long-term trend for Adaptive Biotechnologies's market capitalization?
- Over 5 years (2020 to 2025), Adaptive Biotechnologies's market capitalization has grown at a -21.6% compound annual growth rate (CAGR), from $8.35B to $2.48B.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.
Ask your AI about Adaptive Biotechnologies's market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude